Global hepatitis C elimination: an investment framework. (October 2020)

• Record Type: Journal Article
• Authors: Pedrana, Alisa; Howell, Jessica; Scott, Nick; Schroeder, Sophia; Kuschel, Christian; Lazarus, Jeffrey V; Atun, Rifat; Baptista-Leite, Ricardo; 't Hoen, Ellen; Hutchinson, Sharon J; Aufegger, Lisa; Peck, Raquel; Sohn, Annette H; Swan, Tracy; Thursz, Mark; Lesi, Olufunmilayo; Sharma, Manik; Thwaites, John; Wilson, David P; Hellard, Margaret
• Is Part Of: Lancet gastroenterology and hepatology. Volume 5:Number 10(2020)
• Page Start: 927
• Page End: 939
• Publication Date: 2020-10
• DOI: 10.1016/S2468-1253(20)30010-8
• Languages: English
• ISSNs: 2468-1253

Abstract

Summary: WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.